Evidence map›Paper›PMID 32193729›Full record

ArticleAIDS and behavior2020

Transgender Women's Experiences Using a Home HIV-Testing Kit for Partner-Testing.

Christine Tagliaferri Rael, Rebecca Giguere, Javier Lopez-Rios, Cody Lentz, Iván C Balán, Alan Sheinfil, Curtis Dolezal, William Brown, Timothy Frasca, Catherine Cruz Torres and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in AIDS and behavior, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Self-Testing as a Hope to Reduce HIV in Transgender Women-Literature Review.International journal of environmental research and public health · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Christine Tagliaferri RaelHIV Center for Clinical and Behavioral Studies at the New York State Psychiatric Institute and Columbia University, 1051 Riverside Dr, New York, NY, 10032, USA. Cr2857@cumc.columbia.edu.
Rebecca GiguereHIV Center for Clinical and Behavioral Studies at the New York State Psychiatric Institute and Columbia University, 1051 Riverside Dr, New York, NY, 10032, USA.
Javier Lopez-RiosHIV Center for Clinical and Behavioral Studies at the New York State Psychiatric Institute and Columbia University, 1051 Riverside Dr, New York, NY, 10032, USA.
Cody LentzHIV Center for Clinical and Behavioral Studies at the New York State Psychiatric Institute and Columbia University, 1051 Riverside Dr, New York, NY, 10032, USA.
Iván C BalánHIV Center for Clinical and Behavioral Studies at the New York State Psychiatric Institute and Columbia University, 1051 Riverside Dr, New York, NY, 10032, USA.
Alan SheinfilDepartment of Psychology, Syracuse University, Syracuse, NY, USA.
Curtis DolezalHIV Center for Clinical and Behavioral Studies at the New York State Psychiatric Institute and Columbia University, 1051 Riverside Dr, New York, NY, 10032, USA.
William BrownHIV Center for Clinical and Behavioral Studies at the New York State Psychiatric Institute and Columbia University, 1051 Riverside Dr, New York, NY, 10032, USA.
Timothy FrascaHIV Center for Clinical and Behavioral Studies at the New York State Psychiatric Institute and Columbia University, 1051 Riverside Dr, New York, NY, 10032, USA.
Catherine Cruz TorresDepartment of Pediatrics, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico, USA.
Raynier CrespoDivision of General Internal Medicine, Department of Medicine, School of Medicine, Center for Vulnerable Populations at Zuckerberg San Francisco General Hospital and Trauma Center, University of California San Francisco, San Francisco, CA, USA.
Sarah IribarrenSchool of Nursing, University of Washington, Seattle, WA, USA.
Cheng-Shiun LeuHIV Center for Clinical and Behavioral Studies at the New York State Psychiatric Institute and Columbia University, 1051 Riverside Dr, New York, NY, 10032, USA.
Irma FeboDepartment of Pediatrics, University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico, USA.
Alex Carballo-DiéguezHIV Center for Clinical and Behavioral Studies at the New York State Psychiatric Institute and Columbia University, 1051 Riverside Dr, New York, NY, 10032, USA.

Funding

The Statistics, Data Science, and Data Management (SDM) CoreP30MH043520 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI Claude Ann Mellins · 2003 to 2026
$48.2M
Training in Biomedical Informatics at Columbia UniversityT15LM007079 · NLM · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI NOEMIE ELHADAD, GEORGE M HRIPCSAK · 1992 to 2026
$28.9M
Tissue pharmacology imaging and modelingU19AI113127 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BUMPUS, NAMANDJE N · 2014 to 2018
$20.7M
Institutional Career Development Core SupplementKL2TR001870 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KANAYA, ALKA M., SARKAR, URMIMALA · 2016 to 2025
$19.7M
University of Puerto Rico Clinical Trials UnitUM1AI069415 · NIAID · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI FEBO, IRMA LUZ, SANTANA-BAGUR, JORGE L. · 2012 to 2021
$15.2M
Social Interventions to address disparities In young adult tobacco useP60MD006902 · NIMHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BIBBINS-DOMINGO, KIRSTEN · 2012 to 2016
$6.4M
UCSF Learning Health System K12 Career Development ProgramK12HS026383 · AHRQ · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GONZALES, RALPH, SARKAR, URMIMALA · 2018 to 2022
$3.6M
Rapid Home Test to Reduce Sexual Risk Behavior in MSM and Transgender WomenR01HD076636 · NICHD · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI CARBALLO-DIEGUEZ, ALEX · 2014 to 2018
$3.1M
The Next Frontier in Diabetes Communication: Promoting Health Literacy in the Era of Secure MessagingR01LM012355 · NLM · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KARTER, ANDREW JOHN, SCHILLINGER, DEAN · 2015 to 2018
$2.8M
Creating Community Driven, Personalized Health Maps for Patients with DiabetesR01LM013045 · NLM · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LYLES, COURTNEY REES · 2018 to 2021
$1.5M
Supplement: Developing Tailored Delivery and Adherence Interventions for use of Long-Acting Biomedical HIV Prevention Strategies by Transgender WomenK01MH115785 · NIMH · UNIVERSITY OF COLORADO DENVER · PI RAEL, CHRISTINE TAGLIAFERRI · 2018 to 2022
$767k
AHRQ HHS K12 HS026383National Institute of Child Health and Human Development R01 AI113127NCATS NIH HHS KL2 TR001870NIAID NIH HHS U19 AI113127NIAID NIH HHS UM1 AI069415NICHD NIH HHS R01 HD076636NIMHD NIH HHS P60 MD006902NIMH NIH HHS K01 MH115785NIMH NIH HHS P30 MH043520NIMH NIH HHS P30 MH43520NLM NIH HHS R01 LM012355NLM NIH HHS R01 LM013045NLM NIH HHS T15 LM007079
6 · The paper itself

Abstract

HIV partner-testing (PT) may represent a unique and empowering HIV prevention strategy for groups that face structural and institutional barriers to HIV testing and care, including transgender women. We report on in-depth interviews (IDIs) with N = 10 transgender women who used HIV self-test kits for three months to screen potential sexual partners in a randomized controlled trial (iSUM; "I'll Show You Mine") that took place in New York City and San Juan, Puerto Rico. Participants were assigned to intervention (supplied with 10 self-test kits immediately) or control groups (received 6 test kits after 3 months). We conducted IDIs with the first N = 10 transgender women to enroll in the intervention group after three months in the study (after participants used kits with partners) to understand their experiences. Themes discussed in IDIs included: partners' reaction to HIV testing, participants' reactions to partners' test results or refusal to test, partners' own reaction to their test results, and decision-making around test use. Data were independently analyzed by two coders. Overwhelmingly, participants' experiences with PT was positive. Participants reported kits were convenient and acceptable to most partners. Transgender women felt that PT could pose additional risk for them; one woman experienced violence related to kit use. Furthermore, the availability of kits appeared to encourage participants and their partners to think about their HIV status and, in some cases, modify sexual behavior. Work suggests that HIV PT could be a viable risk-reduction strategy for transgender women.

Indexed as

Reagent Kits, DiagnosticSexual PartnersAdultAIDS SerodiagnosisFemaleHIV InfectionsHumansInterviews as TopicMaleMass ScreeningNew York CityPuerto RicoQualitative ResearchRandomized Controlled Trials as TopicSelf CareSerologic TestsReagent Kits, DiagnosticHIVHIV/AIDSHIV self-testHIV testingMale partnersOraQuickPartner HIV testingSecondary distributionTransgender womenTrans womenTranswomen

Identifiers

PMID32193729
PMCPMC7725406

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.